Home/Filings/4/0000899243-20-027697
4//SEC Filing

COHEN MARC A 4

Accession 0000899243-20-027697

CIK 0001662579other

Filed

Oct 5, 8:00 PM ET

Accepted

Oct 6, 9:28 PM ET

Size

17.7 KB

Accession

0000899243-20-027697

Insider Transaction Report

Form 4
Period: 2020-10-06
COHEN MARC A
Director10% Owner
Transactions
  • Conversion

    Common Stock

    2020-10-06+237,149370,024 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2020-10-06+2,484,4252,484,425 total(indirect: By Cobro Ventures Opportunity Fund, L.P.)
  • Conversion

    Series Seed Preferred Stock

    2020-10-062,000,0000 total(indirect: See Footnote)
    Common Stock (237,149 underlying)
  • Conversion

    Series A Preferred Stock

    2020-10-0612,500,0000 total(indirect: See Footnote)
    Common Stock (1,482,183 underlying)
  • Conversion

    Common Stock

    2020-10-06+1,482,1831,852,207 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2020-10-06$19.00/sh+5,030$95,5705,030 total
  • Conversion

    Series B Preferred Stock

    2020-10-0620,952,4030 total(indirect: By Cobro Ventures Opportunity Fund, L.P.)
    Common Stock (2,484,425 underlying)
Footnotes (3)
  • [F1]Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.
  • [F2]Shares held by Reporting Person as trustee of the Marc Andrew Cohen Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  • [F3]Shares held by Cobro Ventures Opportunity Fund, L.P. ("Cobro Ventures"). The Reporting Person serves as a manager of Cobro Opportunity Fund GP, LLC, the general partner of Cobro Ventures, and may be deemed to exercise voting and investment power over the shares held by Cobro Ventures. The Reporting Person disclaims beneficial ownership of the shares held by Cobro Ventures except to the extent of his pecuniary interest therein.

Issuer

C4 Therapeutics, Inc.

CIK 0001662579

Entity typeother

Related Parties

1
  • filerCIK 0001132945

Filing Metadata

Form type
4
Filed
Oct 5, 8:00 PM ET
Accepted
Oct 6, 9:28 PM ET
Size
17.7 KB